These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 27167755)

  • 1. Metabolic Testing for Adults in a State Medicaid Program Receiving Antipsychotics: Remaining Barriers to Achieving Population Health Prevention Goals.
    Morrato EH; Campagna EJ; Brewer SE; Dickinson LM; Thomas DS; Miller BF; Dearing J; Druss BG; Lindrooth RC
    JAMA Psychiatry; 2016 Jul; 73(7):721-30. PubMed ID: 27167755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of baseline serum glucose and lipid testing in users of second-generation antipsychotic drugs: a retrospective, population-based study of Medicaid claims data.
    Morrato EH; Newcomer JW; Allen RR; Valuck RJ
    J Clin Psychiatry; 2008 Feb; 69(2):316-22. PubMed ID: 18251625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic testing rates in 3 state Medicaid programs after FDA warnings and ADA/APA recommendations for second-generation antipsychotic drugs.
    Morrato EH; Druss B; Hartung DM; Valuck RJ; Allen R; Campagna E; Newcomer JW
    Arch Gen Psychiatry; 2010 Jan; 67(1):17-24. PubMed ID: 20048219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose Testing for Adults Receiving Medicaid and Antipsychotics: A Population-Based Prescriber Survey on Behaviors, Attitudes, and Barriers.
    Morrato EH; Brewer SE; Campagna EJ; Dickinson LM; Thomas DS; Druss BG; Miller BF; Newcomer JW; Lindrooth RC
    Psychiatr Serv; 2016 Jul; 67(7):798-802. PubMed ID: 27032657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of monitoring for metabolic effects associated with second generation antipsychotics in patients with schizophrenia on public insurance.
    Moeller KE; Rigler SK; Mayorga A; Nazir N; Shireman TI
    Schizophr Res; 2011 Mar; 126(1-3):117-23. PubMed ID: 21168994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Examining quality of care for individuals treated for mental health using the HEDIS mental health quality measures.
    Ng-Mak D; Rajagopalan K
    Curr Med Res Opin; 2019 Jan; 35(1):87-95. PubMed ID: 30286663
    [No Abstract]   [Full Text] [Related]  

  • 8. Risk of arrest in persons with schizophrenia and bipolar disorder in a Florida Medicaid program: the role of atypical antipsychotics, conventional neuroleptics, and routine outpatient behavioral health services.
    Van Dorn RA; Andel R; Boaz TL; Desmarais SL; Chandler K; Becker MA; Howe A
    J Clin Psychiatry; 2011 Apr; 72(4):502-8. PubMed ID: 21527125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of monitoring for glucose and lipid dysregulation in adult Medi-Cal patients newly started on antipsychotics.
    Barnett M; VonMuenster S; Wehring H; Popish S; McDonald K; Walker VM; Perry P
    Ann Clin Psychiatry; 2010 Feb; 22(1):9-18. PubMed ID: 20196978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Metabolic testing rates after initiation of antipsychotic treatment in persons initially treated by conventional mood-stabilizers].
    Verdoux H; Gaudron Y; Auleley GR; Deligne J; Blum-Boisgard C; Thiébaut A; Tournier M
    Encephale; 2013 May; 39 Suppl 1():S22-8. PubMed ID: 23246328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Clinical Setting and Management Approach in Metabolic Testing Among Youths and Adults Treated With Antipsychotics.
    Nicol GE; Campagna EJ; Garfield LD; Newcomer JW; Parks JJ; Morrato EH
    Psychiatr Serv; 2016 Jan; 67(1):128-32. PubMed ID: 26325456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescribing of antipsychotics in UK primary care: a cohort study.
    Marston L; Nazareth I; Petersen I; Walters K; Osborn DP
    BMJ Open; 2014 Dec; 4(12):e006135. PubMed ID: 25524544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of second-generation antipsychotic treatment on psychiatric hospitalization in Medicaid beneficiaries with bipolar disorder.
    Jing Y; Johnston SS; Fowler R; Bates JA; Forbes RA; Hebden T
    J Med Econ; 2011; 14(6):777-86. PubMed ID: 21954966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Young People With Antipsychotic Medications in the United States.
    Olfson M; King M; Schoenbaum M
    JAMA Psychiatry; 2015 Sep; 72(9):867-74. PubMed ID: 26132724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring of Recommended Metabolic Laboratory Parameters Among Medicaid Recipients on Second-Generation Antipsychotics in Federally Qualified Health Centers.
    Uzal NE; Chavez B; Kosirog ER; Billups SJ; Saseen JJ
    Ann Pharmacother; 2018 Feb; 52(2):160-165. PubMed ID: 28884591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations, Outcomes (REACH-OUT) study: real-world clinical practice in schizophrenia.
    Joshi K; Mao L; Biondi DM; Millet R
    BMC Psychiatry; 2018 Jan; 18(1):24. PubMed ID: 29378547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of Metabolic Monitoring in Youth and Adult Medicaid Recipients Prescribed Antipsychotics.
    Edelsohn GA; Parthasarathy M; Terhorst L; Karpov IO; Schuster J
    J Manag Care Spec Pharm; 2015 Sep; 21(9):769-77, 777a-777cc. PubMed ID: 26308224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003.
    Morrato EH; Dodd S; Oderda G; Haxby DG; Allen R; Valuck RJ
    Clin Ther; 2007 Jan; 29(1):183-95. PubMed ID: 17379060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simulated Effects of Policies to Reduce Diabetes Risk Among Adults With Schizophrenia Receiving Antipsychotics.
    Mulcahy AW; Normand SL; Newcomer JW; Colaiaco B; Donohue JM; Lave JR; Keeler E; Sorbero MJ; Horvitz-Lennon M
    Psychiatr Serv; 2017 Dec; 68(12):1280-1287. PubMed ID: 28859580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adherence to antipsychotics and cardiometabolic medication: association with health care utilization and costs.
    Hansen RA; Maciejewski M; Yu-Isenberg K; Farley JF
    Psychiatr Serv; 2012 Sep; 63(9):920-8. PubMed ID: 22706887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.